scispace - formally typeset
Search or ask a question

Showing papers by "Anna Podsędek published in 2012"

Journal Article•DOI•
Hypolipidemic and antioxidant effects of hydroxycinnamic acids, quercetin, and cyanidin 3-glucoside in hypercholesterolemic erythrocytes (in vitro study).

[...]

Piotr Duchnowicz, Marlena Broncel, Anna Podsędek, Maria Koter-Michalak
01 Jun 2012-European Journal of Nutrition
TL;DR: The results indicate that flavonols and anthocyanins have higher antioxidant properties and higher influence on cholesterol concentration in erythrocytes membranes than simple hydroxycinnamic acids.
Abstract: Objective Four polyphenols: ferulic acid and p-coumaric acid (hydroxycinnamic acids), quercetin (flavonol) and cyanidin 3-glucoside (anthocyanin) were selected, and their antioxidant properties and their influence on cholesterol concentration in hypercholesterolemic and normal erythrocytes were investigated

57 citations

Journal Article•DOI•
Effect of polyphenols extracts from Brassica vegetables on erythrocyte membranes (in vitro study).

[...]

Piotr Duchnowicz, Milena Bors, Anna Podsędek, Maria Koter-Michalak, Marlena Broncel 
01 Nov 2012-Environmental Toxicology and Pharmacology
TL;DR: The results indicate that polyphenols from red cabbage and Brussels sprout may directly influence erythrocyte membrane properties.

34 citations

Patent•
Polyphenolic formulation, its preparation and use

[...]

Marcin Różalski1, Jacek Golanski1, C. Watala1, Magdalena Labieniec1, Maria Koziołkiewicz1, Anna Podsędek1, Dorota Sosnowska1, Małgorzata Redzynia1, Tomasz Przygodzki1, Boguslawa Luzak1, Magdalena Boncler1 •
Lodz University of Technology1
07 Aug 2012
TL;DR: In this paper, a polyphenolic formulation having antithrombotic activity containing the defatted spent hops extract was proposed for use in the treatment and prevention of cardiovascular diseases against cancer.
Abstract: The invention relates to a polyphenolic formulation having antithrombotic activity containing the defatted spent hops extract. Invention further relates to the formulation preparation process. The formulation according to the invention can be used in the antithrombotic treatment and antithrombotic prophylaxis against cardiovascular diseases.